(123): a study on a formalin-inactivated, non-adjuvanted CVB1 vaccine showed it to be highly effective, generating strong neutralizing antibodies and protecting against both acute CVB1 infection in NOD mice and CVB1-induced diabetes in SOCS1-tg mice. The gene discussed is SOCS1; the disease is diabetes mellitus.